HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1 - 5

Query Trace: Cardiovascular Diseases and CYP2D6[original query]

Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana Similar articles in PubMed
The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population. Pharmacogenetics and genomics 2019 May . Poulussen Fenna C P, Peters Bas J, Hua Ken Ho, Houthuizen Patrick, Grouls Rene J, Deenen Maarten Similar articles in PubMed
Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. Frontiers in genetics 2012 3 . Roco A, Quiñones L, Agúndez JA, García-Martín E, Squicciarini V, Miranda C, Garay J, Farfán N, Saavedra I, Cáceres D, Ibarra C, Varela N Similar articles in PubMed
The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients. Journal of clinical pharmacy and therapeutics 2006 Feb 31 (1): 99-109. Ismail R, Teh L Similar articles in PubMed
Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study. Journal of clinical pharmacy and therapeutics 2004 Dec 29 (6): 559-64. Teh L K, Zilfalil B A, Marina I, Rosemi B S, Ismail Similar articles in PubMed